Exagen (XGN) Operating Leases (2022 - 2026)

Exagen has reported Operating Leases for 5 years, with the latest figure at $111000.0 in Q1 2026.

• For the quarter ending Q1 2026, Operating Leases fell 91.89% year-over-year to $111000.0; the trailing twelve-month figure through Mar 2026 stood at $111000.0 (down 91.89% YoY), and the FY2025 full-year result was $438000.0, down 73.68% from the prior year.
• Operating Leases for Q1 2026 stood at $111000.0, down from $438000.0 in the prior quarter.
• The five-year high for Operating Leases was $6.2 million in Q1 2022, with the low at $111000.0 in Q1 2026.
• Historically, Operating Leases has averaged $2.9 million across 5 years, with a median of $2.5 million in 2024.
• Annual changes were most pronounced in 2023 — Operating Leases slumped 32.44% — and 2026, when it tumbled 91.89%.
• Exagen's Operating Leases stood at $4.5 million in 2022, then slumped by 38.57% to $2.8 million in 2023, then tumbled by 39.71% to $1.7 million in 2024, then plunged by 73.68% to $438000.0 in 2025, then slumped by 74.66% to $111000.0 in 2026.
• The last three Operating Leases figures came in at $111000.0 (Q1 2026), $438000.0 (Q4 2025), and $759000.0 (Q3 2025), per Business Quant data.